Skip to main content
Clinical Trials/CTRI/2024/02/062510
CTRI/2024/02/062510
Recruiting
未知

A Clinical Study to evaluate the moisturization potential of Piramal Lacto Calamine Light Moisturising Gel. - NI

Piramal Pharma Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Piramal Pharma Limited
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Gender: Male or Female 18 to 40
  • Subjects willing to give written informed consent
  • Women of child bearing potential must have a negative urine pregnancy test prior to study entry.
  • Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events.
  • Are willing to avoid prolonged exposure of the treatment area
  • To ultraviolet radiation (natural or artificial) for the duration of the study.

Exclusion Criteria

  • Subjects who are pregnant, breast\-feeding, or planning to become pregnant during the study.
  • Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
  • Have open sores or open lesions in the treatment area(s).
  • Have any condition that, in the opinion of the investigator, would confound the safety or efficacy assessments of the product.
  • Have participated in any interventional clinical trial in the previous 90 days.
  • Have a known sensitivity to any of the constituents of the test product
  • Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.
  • Have not skin related issues

Outcomes

Primary Outcomes

Not specified

Similar Trials